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Letters to the Editor
RE: ‘‘DO WE NEED GENOMIC RESEARCH FOR THE PREVENTION OF COMMON DISEASES
WITH ENVIRONMENTAL CAUSES?’’
Khoury et al. (1) nicely reviewed some of the reasons why
studying the genetic component of complex disease etiology
might be useful. We agree in principle that epidemiologic
research should continue to investigate both the genetic and
nongenetic determinants of common disorders. However, we
do not believe that the arguments of Khoury et al. invalidate
Merikangas and Risch’s (2) thesis that genetic research for
diseases appearing to be highly amenable to environmental
modification should be of lower priority than genetic re-
search for diseases that have an implicated genetic basis
but which cannot now be treated or prevented with environ-
mental changes. Berrettini et al. (3) commented further on
this thesis in their letter in Science published recently.
In essence, Khoury et al. state that even for those complex
diseases for which intervening upon environmental risk fac-
tors is known to be useful, potential genetic characteristics
are also worth studying because of the existence of gene-
environment interactions. These interactions may amplify
the public health benefits of focusing interventions on those
individuals with the highest combined genetic and environ-
mental risks.
The crucial issue therefore is how important gene-
environment interactions can reasonably be expected to be.
Stating that ‘‘almost all human diseases result from inter-
actions between genetic variants and the environment’’
(1, p. 800) does not address the problem. It suggests that
gene-environment interactions may play a large role in the
etiology of complex traits, that is, that the environmental ef-
fect is much larger in those carrying the deleterious genetic
traits than in those who don’t. Yet, where is the evidence
supporting this? Khoury et al. indicate areas of potential inter-
est, such as family-centered interventions, but whether this
will improve prevention strategies for common diseases
remains to be demonstrated.
In a recent study based on careful measurement of 10
environmental exposures and 275 single nucleotide poly-
morphisms from 11 genes involved in the reverse choles-
terol transport pathway, we found that a much larger fraction
of the population variance in high density lipoprotein cho-
lesterol was explained by body mass index rather than by
the genetic variants (4). This was of course expected as the
rapid changes in hypercholesterolemia, body mass index,
and diabetes observed over the last 10 years could not plau-
sibly have arisen from genetic causes (5). However, the
very modest role of gene-environment interactions in ex-
plaining the variation in high density lipoprotein cholesterol
was still very surprising. Indeed, the nongenetic (E) and
genetic (G) main effects explained 28 percent and 4 percent,
respectively, of the high density lipoprotein cholesterol
variance, while the fraction explained by the combined
effects of G 3 G, E 3 E, and G 3 E interactions was only
2 percent.
We do not pretend that our study provides the final word
on the question. In fact, there is plenty of room for specu-
lation as to why we may have underestimated the impor-
tance of interactions. On the other hand, there is very little
published evidence that contradicts our findings. It appears
therefore premature to argue that it is because of gene-
environment interactions that Merikangas and Risch’s thesis
should be rejected. Consider again the current obesity epi-
demic. Its extremely rapid worldwide progression and the
fact that no ceiling prevalence of obesity has been observed
in any population do not rule out a major role of gene-
environment interactions but tend to speak against it.
Epidemiologic research still needs to establish whether
complex human diseases result substantially from interac-
tions between genetic variants and the environment. While
this objective certainly warrants more genetic-environmental
research, it should not be taken for granted that the eventual
findings will have great public health relevance, and the quest
should not delay implementing public health interventions
on environmental factors at the population level.
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